Inventory increased 534.4%
Inventory changed +534.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +534.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +112596 basis points from the comparable as-filed period.
Research & development changed -53.7% from the comparable as-filed period.
Gross margin changed +2376 basis points from the comparable as-filed period.
Revenue changed +199.3% from the comparable as-filed period.
Current assets changed +26.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -18.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed -16.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current liabilities changed +38.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Shares outstanding changed +141.6% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Stock-based compensation changed +81.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed -14.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital changed +19.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed +1858 basis points from the comparable as-filed period.
Cost of revenue changed +85.1% from the comparable as-filed period.
Gross profit changed +387.7% from the comparable as-filed period.
Inventory / revenue changed +26313 basis points from the comparable as-filed period.
SBC / revenue changed -4576 basis points from the comparable as-filed period.
Operating income changed -8.4% from the comparable as-filed period.
Free-cash-flow margin changed +96461 basis points from the comparable as-filed period.
Operating cash-flow margin changed +98320 basis points from the comparable as-filed period.
R&D / revenue changed -69310 basis points from the comparable as-filed period.
Working capital / assets changed +194 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +13.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Capital expenditure changed from 0 to 84000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Current long-term debt changed -6.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed -8.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.